Investments
21Portfolio Exits
15About RS Investments
RS Investments offers investment management solutions for institutional and individual investors and the advisors who serve them. The firm's specialized investment platform supports distinct investment teams, each utilizing disciplined and repeatable investment processes to deliver research-driven value, growth and alternative strategies in U.S. and global equity markets, as well as strategies in global natural resources and fixed income.
Want to inform investors similar to RS Investments about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest RS Investments News
Dec 19, 2022
Vanguard announced plans to modify the investment advisory arrangement of the US$ 3.1 billion Vanguard Mid-Cap Growth Fund. RS Investments will no longer serve as an advisor to the fund, and the firm’s portion of the fund (approximately 20% of fund assets) will be transitioned to Frontier Capital Management Co., LLC, an existing manager on…
RS Investments Investments
21 Investments
RS Investments has made 21 investments. Their latest investment was in VitalStream Holdings as part of their Unattributed VC - III on June 6, 2004.
RS Investments Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
6/9/2004 | Unattributed VC - III | VitalStream Holdings | $11M | Yes | ||
8/21/2003 | Private Equity - II | Penwest Pharmaceuticals | $52.66M | Yes | Allianz, Deephaven Capital Management, Dorset Management Corporation, Downsview Capital, Highbridge Capital Management, Knott Partners, Mainfield Enterprises, Narragansett Asset Management, OppenheimerFunds, Perceptive Advisors, Point72 Asset Management, ProMed Capital, Putnam Investments, RS Emerging Growth Fund, RS Investments, Rx Health Management, SF Capital Group, and Welch Capital Partners | |
12/10/2002 | Unattributed VC | Vertro | $5.8M | Yes | ||
1/18/2002 | Unattributed VC - IV | |||||
12/24/2001 | Unattributed VC - V |
Date | 6/9/2004 | 8/21/2003 | 12/10/2002 | 1/18/2002 | 12/24/2001 |
|---|---|---|---|---|---|
Round | Unattributed VC - III | Private Equity - II | Unattributed VC | Unattributed VC - IV | Unattributed VC - V |
Company | VitalStream Holdings | Penwest Pharmaceuticals | Vertro | ||
Amount | $11M | $52.66M | $5.8M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | Allianz, Deephaven Capital Management, Dorset Management Corporation, Downsview Capital, Highbridge Capital Management, Knott Partners, Mainfield Enterprises, Narragansett Asset Management, OppenheimerFunds, Perceptive Advisors, Point72 Asset Management, ProMed Capital, Putnam Investments, RS Emerging Growth Fund, RS Investments, Rx Health Management, SF Capital Group, and Welch Capital Partners | ||||
Sources |
RS Investments Portfolio Exits
15 Portfolio Exits
RS Investments has 15 portfolio exits. Their latest portfolio exit was Four51 on March 03, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
3/3/2021 | Acquired | 6 | |||
5/10/2013 | Acquired | 5 | |||
5/23/2011 | Acquired | ||||
Date | 3/3/2021 | 5/10/2013 | 5/23/2011 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 6 | 5 |
RS Investments Team
6 Team Members
RS Investments has 6 team members, including current Chief Executive Officer, Matthew H Scanlan.
Name | Work History | Title | Status |
|---|---|---|---|
Matthew H Scanlan | Chief Executive Officer | Current | |
Name | Matthew H Scanlan | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Chief Executive Officer | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.